INVO Fertility, Inc. (IVF)
NASDAQ: IVF · Real-Time Price · USD
2.210
+0.040 (1.84%)
May 20, 2025, 9:50 AM - Market open
INVO Fertility Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
FY 2024 | FY 2023 |
Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Revenue | 6.53 | - |
Cost of Revenue | 3.66 | - |
Gross Profit | 2.87 | - |
Selling, General & Admin | 9.08 | 2.16 |
Research & Development | 0.49 | 0.98 |
Operating Expenses | 10.49 | 3.13 |
Operating Income | -7.61 | -3.13 |
Interest Expense | -1.06 | -0.14 |
Other Non Operating Income (Expenses) | 0.09 | - |
EBT Excluding Unusual Items | -8.58 | -3.28 |
Gain (Loss) on Sale of Investments | 0.01 | - |
Gain (Loss) on Sale of Assets | -0.51 | - |
Other Unusual Items | -0.04 | - |
Pretax Income | -9.12 | -3.28 |
Income Tax Expense | -0.02 | - |
Net Income | -9.1 | -3.28 |
Net Income to Common | -9.1 | -3.28 |
Shares Outstanding (Basic) | 0 | 0 |
Shares Outstanding (Diluted) | 0 | 0 |
Shares Change (YoY) | 44.89% | - |
EPS (Basic) | -29.39 | -15.35 |
EPS (Diluted) | -30.19 | -15.36 |
Free Cash Flow | -3.16 | - |
Free Cash Flow Per Share | -10.20 | - |
Gross Margin | 44.00% | - |
Operating Margin | -116.56% | - |
Profit Margin | -139.25% | - |
Free Cash Flow Margin | -48.35% | - |
EBITDA | -6.69 | - |
EBITDA Margin | -102.48% | - |
D&A For EBITDA | 0.92 | - |
EBIT | -7.61 | -3.13 |
EBIT Margin | -116.56% | - |
Revenue as Reported | 6.53 | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.